Insider Trading History of Taylor Michael Douglas


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Taylor Michael Douglas since year 2005. The trader's CIK number is 1494875. At the time of the last reporting, Taylor Michael Douglas was the Director of Deciphera Pharmaceuticals, Inc. . (stock ticker symbol DCPH). See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Taylor Michael Douglas since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-11-01 DCPH Deciphera Pharmaceuticals, Inc. Sale 7,500 45.02 337,642
2019-11-01 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 7,500 1.89 14,175
2019-09-11 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 22,500 1.89 42,525
2019-09-11 DCPH Deciphera Pharmaceuticals, Inc. Sale 22,500 35.11 789,907
2019-09-03 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 7,500 1.89 14,175
2019-09-03 DCPH Deciphera Pharmaceuticals, Inc. Sale 7,500 36.26 271,972
2019-08-13 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 22,500 1.89 42,525
2019-08-13 DCPH Deciphera Pharmaceuticals, Inc. Sale 22,500 41.06 923,827
2019-02-15 DCPH Deciphera Pharmaceuticals, Inc. Sale 4,934 28.01 138,191
2019-02-19 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 3,997 1.89 7,554
2019-02-19 DCPH Deciphera Pharmaceuticals, Inc. Sale 3,997 30.00 119,913
2019-02-14 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 500 1.89 945
2019-02-15 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 4,934 1.89 9,325
2019-02-14 DCPH Deciphera Pharmaceuticals, Inc. Sale 500 28.00 14,000
2019-02-05 DCPH Deciphera Pharmaceuticals, Inc. Option Ex 1,700 1.89 3,213
2019-02-05 DCPH Deciphera Pharmaceuticals, Inc. Sale 1,700 28.01 47,611

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taylor Michael Douglas (Director of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month